Pfizer has made a new and improved bid to acquire AstraZeneca with an offer worth £69.3 billion pounds ($116.6 billion) or £55 a share – and says this is its best and final offer for the firm.

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Pfizer has officially declared its £69 billion bid to acquire AstraZeneca dead - but hasn't ruled out another attempt in a few months' time. The US company has been in open pursuit of AstraZeneca ...

A Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc (NYSE:PFE) $107.5 million in damages, concluding that AstraZeneca’s blockbuster lung cancer drug ...

In July, AstraZeneca declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” Earlier, Pfizer raised its 2024 guidance to $8.5 billion from $8 ...

The company is already working with multiple large hospitals in the U.S. and Israel, as well as drug companies, including AstraZeneca and Pfizer. Promise Bio is now emerging from stealth with a ...

The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found. Two jabs of either vaccine give a similar level of ...

AstraZeneca: It boasts a diversified geographical ... The stock has surged 11.5% year to date. Pfizer: It is one of the largest and most successful drugmakers in the field of oncology.